COPENHAGEN, Denmark, Nov.02, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live...Read More
Milled production for Q3 increased by 17% against Q2 2017 averaging 1,934 tpd; September milled production increased by 8% versus August 2017 averaging 2,055 tpdFree cash flows expected imminentlyQ3 performance expected to support a strong Q4 and year-end exit rate that should drive robust 2018...Read More
TORONTO, Oct. 16, 2017 /CNW/ - Chris Buncic, President and CEO, Ascendant Resources Inc. (ASND), joined Shaun McIver, Chief Client Officer, Equity Capital Markets, TMX Group, to open the market. Ascendant Resources Inc. is a mining company focused on its producing El Mochito zinc, silver and lead...Read More
ZnEq grades proving to be consistently above current mining gradeKey Highlights*: (true and apparent widths): Exploration Areas in 2017 Infill HolesHOLE 10875 - 5.5m at 45.5% ZnEq, 5.2% zinc, 2.7% lead, 2,297 g/t silver and 0.98% copperHOLE 10887 - 23.4m at 7.7% ZnEq....Read More
TORONTO, Sept.28, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce the appointment of Ms. Petra Decher, CPA, CA to the Company's Board of Directors and Mr. Stephen Shefsky to the position of Lead Director of...Read More
COPENHAGEN, Denmark, Sept.27, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,800,000 American Depositary Shares ("ADSs"), each of which represents one ordinary share of As...Read More
COPENHAGEN, Denmark, Sept.26, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, announced today that it has dosed subjects in a phase 1 trial of Tran...Read More
COPENHAGEN, Denmark, Sept.26, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $125,000,000 of American Depositary Shares ("ADSs"), each of which represents one ordina...Read More
Second consecutive month of positive adjusted EBITDATonnes milled increased to 1,903 tpd, up 9.8% from Q2 average and 53% from January 2017Fleet renewal in-process with new equipment orderedTORONTO, Sept.20, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("As...Read More
TORONTO, Sept.13, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce the launch of its 360 ? virtual tour of the El Mochito Mine located in Honduras. The El Mochito Mine's virtual tour provides an in-depth view...Read More
NEW YORK, Sept. 5, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Ascendant Resources Inc. (TSX: ASND; OTCQX: ASDRF), a mining company focused on operations in Honduras, has qualified to trade on the...Read More
TORONTO, Sept.05, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") announces that effective immediately its common shares have commenced trading in the United States under the symbol "ASDRF" on the OTCQX (R) Best Market ("OTCQX")....Read More
COPENHAGEN, Denmark, Sept.05, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced upcoming posters and presentations related to its rar...Read More
- Clinical Pipeline Expands to Include TransCon PTH while Phase 3 Program for TransCon Growth Hormone Advances - - Conference Call Today at 8:00 a.m. Eastern Time - COPENHAGEN, Denmark, Aug.18, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes i...Read More
Adjusted EBITDA1 of $0.7 million for month of July1,853 tonnes milled per day and 57,458 total tonnes milled during the month of July, an increase of 7% compared to Q2/17; August reporting continue improvementAdoption of advance notice by-lawTORONTO, Aug.14, 2017(GLOBE NEWSWIRE) -- Ascendant Res...Read More
COPENHAGEN, Denmark, Aug.08, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in three upcoming in...Read More
COPENHAGEN, Denmark, Aug.03, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live...Read More
TORONTO, July18, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX-V:ASND) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce that, further to a June 28, 2017 press release, it has received final approval from the Toronto Stock Exchange ("TSX") to graduate from the TSX Venture E...Read More
Milled production rises 15% against the first quarter 2017Second quarter performance 4% ahead of guidance on equivalent metal production basisTORONTO, July17, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX-V:ASND) (FRA:2D9) ("Ascendant" or the "Company") announces zinc equivalent metal...Read More
TORONTO, ONTARIO--(Marketwired - June 29, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND)(FRANKFURT:2D9) ("Ascendant" or the "Company") is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Ventur...Read More